Unknown

Dataset Information

0

Discovery of New Cyclopentaquinoline Analogues as Multifunctional Agents for the Treatment of Alzheimer's Disease.


ABSTRACT: Here we report the two-step synthesis of 8 new cyclopentaquinoline derivatives as modifications of the tetrahydroacridine structure. Next, the biological assessment of each of them was performed. Based on the obtained results we identified 6-chloro-N-[2-(2,3-dihydro-1H-cyclopenta[b]quinolin-9-ylamino)-hexyl]]-nicotinamide hydrochloride (3e) as the most promising compound with inhibitory potencies against EeAChE and EqBuChE in the low nanomolar level 67 and 153 nM, respectively. Moreover, 3e compound is non-hepatotoxic, able to inhibit amyloid beta aggregation, and shows a mix-type of cholinesterase's inhibition. The mixed type of inhibition of the compound was confirmed by molecular modeling. Then, yeast three-hybrid (Y3H) technology was used to confirm the known ligand-receptor interactions. New derivatives do not show antioxidant activity (confirmed by the use of two different tests). A pKa assay method was developed to identify the basic physicochemical properties of 3e compound. A LogP assay confirmed that 3e compound fulfills Lipinsky's rule of five.

SUBMITTER: Czarnecka K 

PROVIDER: S-EPMC6386991 | biostudies-literature | 2019 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Discovery of New Cyclopentaquinoline Analogues as Multifunctional Agents for the Treatment of Alzheimer's Disease.

Czarnecka Kamila K   Girek Małgorzata M   Kręcisz Paweł P   Skibiński Robert R   Łątka Kamil K   Jończyk Jakub J   Bajda Marek M   Kabziński Jacek J   Majsterek Ireneusz I   Szymczyk Piotr P   Szymański Paweł P  

International journal of molecular sciences 20190124 3


Here we report the two-step synthesis of 8 new cyclopentaquinoline derivatives as modifications of the tetrahydroacridine structure. Next, the biological assessment of each of them was performed. Based on the obtained results we identified 6-chloro-<i>N</i>-[2-(2,3-dihydro-<i>1H</i>-cyclopenta[b]quinolin-9-ylamino)-hexyl]]-nicotinamide hydrochloride (<b>3e</b>) as the most promising compound with inhibitory potencies against EeAChE and EqBuChE in the low nanomolar level 67 and 153 nM, respective  ...[more]

Similar Datasets

| S-EPMC7763995 | biostudies-literature
| S-EPMC9395670 | biostudies-literature
| S-EPMC11246588 | biostudies-literature
| S-EPMC8512147 | biostudies-literature
| S-EPMC6080388 | biostudies-literature
| S-EPMC6272137 | biostudies-literature
| S-EPMC6222323 | biostudies-literature
| S-EPMC10459044 | biostudies-literature
| S-EPMC8881077 | biostudies-literature
| S-EPMC4919181 | biostudies-other